NexImmune, Inc. Common Stock
NEXI
NEXI was delisted on the 11th of July, 2024.
13 hedge funds and large institutions have $409K invested in NexImmune, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
8% more funds holding
Funds holding: 12 → 13 (+1)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
52% less capital invested
Capital invested by funds: $858K → $409K (-$450K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$13.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.14K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.82K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$24 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$33.5K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$239 |
| 3 |
Wells Fargo
San Francisco,
California
|
-$39 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $138K | -$33.5K | -9,947 | -17% |
|
|
SPC
2
Slate Path Capital
New York
| $102K | – | – | – |
|
|
ECG
3
EPIQ Capital Group
San Francisco,
California
| $43.1K | – | – | – |
|
4
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $34.9K | – | – | – |
|
5
Vanguard Group
Malvern,
Pennsylvania
| $33.1K | – | – | – |
|
|
RJA
6
Raymond James & Associates
St Petersburg,
Florida
| $29.8K | – | – | – |
|
|
7
JP Morgan Chase
New York
| $11.1K | +$13.5K | +4,000 | New |
|
8
Comerica Bank
Dallas,
Texas
| $8.99K | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $5.85K | +$1.82K | +541 | +34% |
|
|
10
UBS Group
Zurich,
Switzerland
| $1.76K | +$2.14K | +637 | +63,700% |
|
11
BNP Paribas Financial Markets
Paris,
France
| $113 | – | – | – |
|
|
12
Bank of America
Charlotte,
North Carolina
| $19 | +$24 | +7 | New |
|
|
13
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$239 | -71 | -41% |
|
|
14
Wells Fargo
San Francisco,
California
| – | -$39 | -7 | Closed |
|
NEXI Hedge Fund Activity: Q2 2024 in Review
13 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q2 2024, worth a combined $409K — down 52% from $858K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new NEXI positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was JP Morgan Chase, opening a new position worth an estimated $13.5K. The largest seller was Sabby Management, cutting an estimated $33.5K.
- 13 institutional investors held NexImmune, Inc. Common Stock (NEXI) as of Q2 2024, up from 12 in Q1 2024.
- Funds reported $409K of NexImmune, Inc. Common Stock stock for Q2 2024, down 52% quarter-over-quarter.
- 2 funds opened new NexImmune, Inc. Common Stock positions in Q2 2024 and 1 closed out, a net change of +1 holder.
- The largest NexImmune, Inc. Common Stock buyer in Q2 2024 was JP Morgan Chase, an estimated $13.5K added.
- The largest NexImmune, Inc. Common Stock seller in Q2 2024 was Sabby Management, an estimated $33.5K sold.
Based on aggregated 13F filings for Q2 2024.